Prosecution Insights
Prosecution Insights
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FERGUSON, JALISA HOLMES | 1 | 61.8% | +56.5% |
| HEITMEIER, KENDALL NICOLE | 1 | 63.9% | +41.7% |
| RODRIGUEZ-GARCIA, VALERIE | 1 | 68.8% | +31.9% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.4% | +40.1% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.3% | +20.3% |
| SEAMAN, D MARGARET M | 1 | 76.6% | +8.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18259696 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | SEAMAN, D MARGARET M | 18d overdue |
| 18559542 | HETEROARYL DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | ABDALHAMEED, MANAHIL MIRGHANI ALI | 17d overdue |
| 18705952 | QUINAZOLINE DERIVATIVE COMPOUND AND USE THEREOF | HEITMEIER, KENDALL NICOLE | — |
| 18692229 | HETEROARYL DERIVATIVE AND USE THEREOF | RODRIGUEZ-GARCIA, VALERIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18559542 | HETEROARYL DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | ABDALHAMEED, MANAHIL MIRGHANI ALI | 17d overdue |
| 18887279 | HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOF | FERGUSON, JALISA HOLMES | — |
| 18705952 | QUINAZOLINE DERIVATIVE COMPOUND AND USE THEREOF | HEITMEIER, KENDALL NICOLE | — |
| 18692229 | HETEROARYL DERIVATIVE AND USE THEREOF | RODRIGUEZ-GARCIA, VALERIE | — |
| 18556883 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | WHITE, DAWANNA SHAR-DAY | — |
| Art Unit | Apps |
|---|---|
| 1621 | 2 |
| 1622 | 1 |
| 1627 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18887279 | HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOF | FERGUSON, JALISA HOLMES | — | §112 | Non-Final OA | — | Pending | Sep 17, 2024 |
| 18705952 | QUINAZOLINE DERIVATIVE COMPOUND AND USE THEREOF | HEITMEIER, KENDALL NICOLE | 1621 | §102§103§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18692229 | HETEROARYL DERIVATIVE AND USE THEREOF | RODRIGUEZ-GARCIA, VALERIE | 1621 | §103§112 | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18559542 | HETEROARYL DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §102§112Other | Non-Final OA | 17d overdue | Pending | Nov 07, 2023 |
| 18556883 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | WHITE, DAWANNA SHAR-DAY | 1627 | §103DPOther | Non-Final OA | — | Pending | Oct 23, 2023 |
| 18259696 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | SEAMAN, D MARGARET M | 1625 | §103§112 | Non-Final OA | 18d overdue | Pending | Jun 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial